<DOC>
	<DOCNO>NCT01667276</DOCNO>
	<brief_summary>This observational study assess experience current depot medroxyprogesterone acetate ( DMPA ) intramuscular ( IM ) client provider try Depo-subQ Uniject offer recommendation introduction method .</brief_summary>
	<brief_title>Acceptability Depo-subQ Uniject</brief_title>
	<detailed_description>This observational study assess experience current depot medroxyprogesterone acetate ( DMPA ) intramuscular ( IM ) client provider try Depo-subQ Uniject offer recommendation introduction method . A total 560 participant enrol study follow group : 360 participant ( 120 Uganda 240 Senegal ) current DMPA IM client seek re-injection DMPA either community health worker ( CHWs ) clinic-based provider ; 18-40 year age ; receive recent DMPA injection 13 week prior enrollment study [ 16 ] . Up 100 participant ( 50 Uganda 50 Senegal ) current DMPA IM client meet inclusion/exclusion criterion want receive injection Depo-subQ Uniject willing complete short questionnaire 80 CHWs ( 40 Uganda 40 Senegal ) 20 clinic-based provider ( Senegal ) train give Depo-subQ Uniject part study</detailed_description>
	<criteria>Age 1840 In general good health ( participant verbally report feel well ) Using DMPA continuously least six month prior enrollment study ( i.e. , least two previous injection ) Received recent DMPA injection 13 week prior enrollment study study clinic family plan provider involve study ( Senegal ) Received recent DMPA injection 13 week prior enrollment study family plan provider involve study ( Uganda ) Desires reinjected DMPA Willing sign inform consent document Willing provide contact information interview three month enrollment .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>AE adverse event</keyword>
	<keyword>AIDS acquire immunodeficiency syndrome</keyword>
	<keyword>ALT ( SGPT ) alanine aminotransferase</keyword>
	<keyword>ART antiretroviral therapy</keyword>
	<keyword>AST ( SGOT ) aspartate aminotransferase</keyword>
	<keyword>DCF data collection form</keyword>
	<keyword>DMC Data Monitoring Committee</keyword>
	<keyword>FDA ( U.S. ) Food Drug Administration</keyword>
	<keyword>GCP Good Clinical Practice guideline</keyword>
	<keyword>HB sAg Hepatitis B surface antigen</keyword>
	<keyword>ICH International Conference Harmonisation</keyword>
	<keyword>IND Investigational New Drug Application</keyword>
	<keyword>IRB Institutional Review Board</keyword>
	<keyword>IU international unit</keyword>
	<keyword>mg milligram ( )</keyword>
	<keyword>mm3 cubic millimeter ( )</keyword>
	<keyword>PCR polymerase chain reaction</keyword>
	<keyword>SAE serious adverse event</keyword>
	<keyword>Âµg microgram</keyword>
	<keyword>ULN upper limit normal range</keyword>
	<keyword>WB Western Blot</keyword>
</DOC>